MAZE Competitors & Alternatives
Compare Maze Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MAZE
Main Stock$36.09
Tradestie Score
33
Market Cap
$1.13B
Analyst Upside
+73.5%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.89
|
$2.18B | - | 52 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$13.10
|
$2.08B | - | 43 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$16.01
|
$2.02B | 834.0 | 36 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$10.55
|
$2.01B | - | 40 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$29.14
|
$1.97B | - | 37 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.28
|
$1.92B | - | 60 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$64.17
|
$1.92B | - | 36 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$58.12
|
$1.90B | - | 35 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$29.04
|
$1.84B | - | 40 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$30.48
|
$1.81B | - | 48 | Compare |
More MAZE Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
218 stocks in this industry